Low-dose interferon composition having reduced adverse event, and application of the same
JP2024175685AInactive Publication Date: 2024-12-18AINOS INC
Patent Information
- Application Number
- JP2024091669
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-06-06
- Filing Date
- 2024-06-05
- Publication Date
- 2024-12-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 00000000_0000_ABST
Abstract
To provide an interferon composition that effectively serves a therapeutic effect, and reduces an adverse event.SOLUTION: Provided are a low-dose interferon composition with a reduced adverse event which is used for treating or preventing a disease in a cat which is generated by virus infection, and application thereof, where the composition contains a low-dose interferon α-2b having a concentration of 160 IU / mL to 100,000 IU / mL, and is administered to an individual which needs it as an oral formulation.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
Biologically stable interferon compositions comprising thimerosal
US4847079A
Insoluble copper-alpha interferon complex
US4871538A
Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
WO2007125605A1